A health worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine for a senior citizen at the Senja-Cashew Community Centre Vaccination Centre, operated by Thomson Medical, in Singapore, on Monday, March 8, 2021. Singapore is introducing a program called�Connect@Changi�that will allow people to enter the island for business and official purposes without having to quarantine, provided they stay in a�bubble-like facility�near Changi Airport for the duration of their visit. Photographer: Wei Leng Tay/Bloomberg (Bloomberg)
1 min read.08 Mar 2021Gurdip Singh, PTI
The packed dormitories housing the foreign labourers were the biggest infection clusters during the peak of the covid-19 outbreak in the island last year
South Korea began vaccinating residents and workers at nursing homes and other at-risk individuals at the end of February, with 316,865 people having received their first shots as of Sunday. (REUTERS)
2 min read.08 Mar 2021Hyonhee Shin,Josh Smith, Reuters
Health officials had been investigating the deaths of eight people with underlying conditions who had adverse reactions after receiving AstraZeneca's COVID-19 vaccine
FILE PHOTO: A vial of Astra Zeneca coronavirus vaccine is seen at a vaccination centre in Westfield Stratford City shopping centre. (REUTERS)
3 min read.07 Mar 2021Aditi Khanna, PTI
People receiving the letters are invited to go online to the national booking service to arrange a jab at a time and location that is convenient for them
File photo: A pharmacist prepares a syringe from a vial of the AstraZeneca coronavirus vaccine. (AP)
2 min read.04 Mar 2021AFP
Most the shortfall is because AstraZeneca has pledged 'best reasonable efforts' to deliver around 100 million doses in that time, but is now on track to supply just 40% of that
FILE - In this file photo dated Friday, Feb. 5, 2021, vials AstraZeneca vaccine ready to be used at the Wellcome Centre in London. Regulators in the U.K. and four other countries said Thursday March 4, 2021, they plan to fast-track the development and authorisation of modified COVID-19 vaccines to ensure drugmakers are able to move swiftly in targeting emerging variants of the coronavirus disease. (AP Photo/Frank Augstein, FILE) (AP)
5 min read.04 Mar 2021Stacy Meichtry,Bojan Pancevski, The Wall Street Journal
Germany, Italy and other large European countries are restricting older people from receiving the shot as France loosens rules
US FDA's scientists confirmed that overall, it's about 66% effective and also said J&J's shot, one that could help speed vaccinations by requiring just one dose instead of two, is safe to use (AP)
3 min read.02 Mar 2021Bloomberg
J&J’s vaccine was authorized for US use on Saturday, adding a third shot to the country’s mass inoculation efforts
Assistant Press Secretary Kevin Munoz said via Twitter that Biden would announce the 'historic partnership'
China's first Ad5-nCoV COVID-19 vaccine was rolled out on Friday
Phase-I clinical trials of the vaccine started on March 16, last year, making it the world's first COVID-19 candidate vaccine that entered clinical trials, the report claims
By tweaking their vaccines, a process that should be easier than coming up with the original shots. (Photo: AP)
1 min read.28 Feb 2021AP
If a variant with a mutated spike protein crops up that the original vaccine can't recognize, companies would swap out that piece of genetic code for a better match — if and when regulators decide that's necessary
J&J’s vaccine differs from authorized shots from Moderna Inc. and the partnership of Pfizer Inc. and BioNTech SE, which rely on messenger RNA to turn cells into vaccine factories (AP)
3 min read.26 Feb 2021Bloomberg
Biden administration officials have said US expects J&J to release 3 million to 4 million shots next week, assuming it’s authorized for use
Johnson & Johnson’s vaccine was 72% effective in the U.S.-based portion of a global study that enrolled more than 43,000 people
FILE PHOTO: Vials of a COVID-19 vaccine candidate, a recombinant adenovirus vaccine named Ad5-nCoV, co-developed by Chinese biopharmaceutical firm CanSino Biologics Inc and a team led by Chinese military infectious disease expert, are pictured in Wuhan, Hubei province, China March 24, 2020. China Daily via REUTERS/File Photo (REUTERS)
1 min read.25 Feb 2021Reuters
The two vaccines are made by CanSino Biologics Inc and Sinopharm's affiliate Wuhan Institute of Biological Product
A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD. (REUTERS)
Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN during a vaccination campaign at AIIMS Delhi (Reuters)
1 min read.22 Feb 2021Krishna N. Das,Neha Arora, Reuters
Bharat Biotech Chairman Krishna Ella said his company would mainly need data from ICMR or WHO on the genetic sequence of any variant to quickly make an effective vaccine
Biological E. Managing Director Mahima Datla said there was no need to be 'overly concerned' about the mutations
Serum Institute, the world's biggest vaccine maker by volume, on Sunday asked for patience from foreign governments awaiting their supply of Covid-19 shots, saying it had been directed to prioritise India's requirements